Cargando…
miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma
Previous studies showed that miR-454 acted as an oncogene or tumor suppressor in cancer. However, its function in HCC remains unknown. In this study, we found that miR-454 expression was upregulated in HCC cell lines and tissues. Knockdown of miR-454 inhibited HCC cell proliferation and invasion and...
Autores principales: | Yu, Lei, Gong, Xuejun, Sun, Lei, Yao, Hong, Lu, Baoling, Zhu, Liying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770768/ https://www.ncbi.nlm.nih.gov/pubmed/26287602 |
Ejemplares similares
-
The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression
por: Yu, Lei, et al.
Publicado: (2016) -
Histone deacetylase 3 is associated with gastric cancer cell growth via the miR-454-mediated targeting of CHD5
por: Xu, Guangru, et al.
Publicado: (2018) -
High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma
por: Li, Yanqing, et al.
Publicado: (2019) -
Interference of miR‐107 with Atg12 is inhibited by HULC to promote metastasis of hepatocellular carcinoma
por: Zhang, Haiming, et al.
Publicado: (2020) -
MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2017)